Sign in

Trial result ·

Photobiomodulation for radiotherapy-induced dysgeusia in head and neck cancer patients: a pilot randomized clinical trial.

Written based on 1 research study on PubMed, searched on 8 Nov 2026.

What was studied

This small pilot trial looked at taste loss during radiotherapy for head and neck cancer. People were split at random into groups of 8. One group got photobiomodulation, or PBM. The other group got zinc sulfate. Taste tests were done before radiotherapy and at sessions 15 and 30.

What they found

Salty taste was the most affected in both groups. At the end, more people in the PBM group kept bitter and sour tastes. So was salty taste. Sweet taste was kept by more people in the zinc group. No gaps between groups were statistically significant at any time.

What it means for patients

The authors say PBM was linked to better kept sour, bitter and salty taste. They call the findings preliminary. They say PBM may be a useful support for taste loss from treatment.

Why it is not certain yet

Only 8 people were in each group. No gaps were statistically significant. The authors call the findings preliminary. The abstract does not give long-term results. It does not say how people felt about taste.

Source

Photobiomodulation for radiotherapy-induced dysgeusia in head and neck cancer patients: a pilot randomized clinical trial.

PubMed · PMID 42986489

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Head and neck cancer publications